In our study, we could show that ovarian cancer patients with high TAAR1 expression in the membrane and/or cytoplasm have a significantly longer overall survival (OS) compared to patients with a low TAAR1 expression and that high membrane TAAR1 expression correlates significantly with low-grade serous ovarian cancer. This evidence concerns the gene TAAR1 and ovarian serous adenocarcinoma.